HOME >> BIOLOGY >> NEWS
Breast cancer can be reversed in laboratory mice, scientists report

(SACRAMENTO, Calif.) -- Breast cancer researchers have demonstrated for the first time that it is possible to block genetic switches in mice that turn cancer on and off -- thus preventing and even reversing breast cancer in the animals. The findings, reported Sunday morning at the 24th Congress of the International Association for Breast Cancer Research, suggest potential new molecular targets for drugs to prevent and potentially eradicate breast cancer in humans.

"It's enormously gratifying," said conference director Robert Cardiff, professor of pathology at UC Davis School of Medicine and Medical Center and an author of the research. "Our findings suggest paths forward that may help us alter the biological path of breast cancer and more successfully treat -- and even potentially prevent -- this cancer in humans."

In new research reported by a team of scientists from Canada, Switzerland and UC Davis, investigators demonstrated that removing a single gene known as beta-1 integrin prevented or halted breast cancer growth in laboratory mice. Beta-1 integrin is a principal regulator of normal breast tissue growth and survival, but if the gene malfunctions, it can directly initiate breast tumors. The new work demonstrates that knocking out the beta-1 integrin gene prevents cancer-prone mice from developing breast tumors, and halts further tumor growth in mice that have already developed breast cancer.

"This study shows that it is absolutely essential to have the beta-1 integrin gene present in order for mammary gland tumors to develop. We now have a good target for biological drug development, and the challenge is to develop an agent that can block its activity," said William J. Muller, professor of biochemistry at McGill University in Montreal and a lead investigator of the study.

In a related presentation, researchers from the University of Pennsylvania reported on a series of experiments using a novel mouse model of human breast cancer, one tha
'"/>

Contact: Claudia Morain
cmmorain@ucdavis.edu
916-762-9855
University of California, Davis - Health System
2-Nov-2003


Page: 1 2 3

Related biology news :

1. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
2. Breastfeeding decreases infant mortality
3. Breast cancer study suggests role for tissue in carcinogenesis
4. Breast self examination increases womens concerns but has no effect on mortality
5. Breast cancer follow-ups no longer guess-work thanks to new physics research
6. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
7. The 4th European Breast Cancer Conference (EBCC4)
8. Breast cancer susceptibility genes play role in DNA repair
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Breast fluid a better option for detecting cancer
11. Breastfeeding may compensate for harmful effects of smoking during pregnancy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... ... to announce it achieved its ISO 9001:2015 registration by certification body Intertek. Modality ... audits, she reviewed and revised all existing Standard Operating Procedures (SOPs) and created ...
(Date:2/7/2020)... ... 2020 , ... dicentra , a leading clinical research ... dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... to probiotics. We are thrilled to join our IPA member colleagues and bring ...
(Date:2/5/2020)... ... February 05, 2020 , ... LabKey has released Sample Manager, ... to sample processing within laboratories. , Built with input from a Product ... fields, LabKey Sample Manager has been designed with an intuitive user interface providing ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra ... mass flow meters and controllers ideal for BioPharm OEMS. Sierra also ... antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing ...
(Date:1/22/2020)... , ... January 20, 2020 , ... ... a partnership with WAVE Electronics, the largest independent electronics distributor in the US, ... purchase Brilliant Smart Home Systems with leading smart home products from a single ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and ... editing. The partners have agreed to co-develop and market a portfolio of CRISPR ... pre-clinical programs. Over the longer-term, the parties aim to develop a COBO branded ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
Breaking Biology Technology:
Cached News: